US Stock MarketDetailed Quotes

CERO CERo Therapeutics

Watchlist
  • 0.251
  • +0.002+0.96%
Trading Nov 21 13:55 ET
37.76MMarket Cap-67P/E (TTM)

About CERo Therapeutics Company

CERo Therapeutics Holdings, Inc. is an immunotherapy company, which engages in development of engineered T cell therapeutics for the treatment of cancer. Its platform is designed to redirect patient-derived T cells to eliminate tumors, creating Chimeric Engulfment Receptor T (CER-T) cells used for spanning hematological malignancies and solid tumors. The company was founded on June 8, 2021 and is headquartered in Oakland, CA.

Company Profile

SymbolCERO
Company NameCERo Therapeutics
Listing DateNov 30, 2021
Founded2021
CEOMr. Chris Ehrlich
MarketNASDAQ
Employees9
Fiscal Year Ends12-31
Address201 Haskins Way,Suite 230
CityOakland
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-215-731-9450
Websitehttp://www.cero.bio

Company Executives

  • Name
  • Position
  • Salary
  • Chris Ehrlich
  • Interim Chairman of the Board and Chief Executive Officer
  • --
  • Andrew Albert Kucharchuk
  • Chief Financial Officer
  • --
  • Dr. Kristen Pierce, PhD
  • Chief Development Officer
  • --
  • Daniel Corey, M.D.
  • Chief Technical Officer and Director
  • 376.04K
  • Brian G. Atwood
  • Director
  • --
  • Kathleen D. Laporte
  • Director
  • --
  • Michael Byrnes
  • Director
  • --
  • Shami J. Patel
  • Director
  • --
  • Dr. Lindsey Rolfe, M.D.
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data